Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 24.44
-0.29 (-1.17%)
Jun 27, 2025, 4:10 PM AEST
Telix Pharmaceuticals Revenue
In the year 2024, Telix Pharmaceuticals had annual revenue of 783.21M AUD with 55.85% growth. Telix Pharmaceuticals had revenue of 209.62M in the quarter ending December 31, 2024, with 48.82% growth.
Revenue
783.21M
Revenue Growth
+55.85%
P/S Ratio
11.12
Revenue / Employee
1.85M
Employees
234
Market Cap
8.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 783.21M | 280.66M | 55.85% |
| Dec 31, 2023 | 502.55M | 342.45M | 213.90% |
| Dec 31, 2022 | 160.10M | 152.50M | 2,007.64% |
| Dec 31, 2021 | 7.60M | 2.38M | 45.71% |
| Dec 31, 2020 | 5.21M | 1.73M | 49.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |
| Mesoblast | 9.16M |
Telix Pharmaceuticals News
- 4 days ago - Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT - GlobeNewsWire
- 7 days ago - Telix Precision Medicine Announces AlFluor Radiochemistry Platform - GlobeNewsWire
- 8 days ago - Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025 - GlobeNewsWire
- 22 days ago - This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
- 24 days ago - Telix Investor Day in New York City on June 11, 2025: Presenting KOLs - GlobeNewsWire
- 6 weeks ago - Telix Pharmeceuticals: Imaging Biomarkers Paving The Way For Theranostics - Seeking Alpha
- 7 weeks ago - Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy - GlobeNewsWire
- 7 weeks ago - Shareholders that Lost Money on Telix Pharmaceuticals Limited (TLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - TLX - Accesswire